Literature DB >> 11920129

The evolutionary history of the two karyotypic groups of the common shrew, Sorex araneus, in Poland.

M Ratkiewicz1, S Fedyk, A Banaszek, L Gielly, W Chetnicki, K Jadwiszczak, P Taberlet.   

Abstract

Genetic variability within and among two karyotypic groups and five chromosome races of the common shrew (Sorex araneus) in Poland was assayed by sequencing a 1023 bp part of the cytochrome b gene (mtDNA) from 28 individuals. Thirty-four variable positions defined 21 distinct haplotypes with a maximum sequence divergence of 0.88%. No significant differentiation in the cytochrome b gene between Western and Eastern Karyotypic groups was found. Haplotype diversity estimates within the races and groups sampled were high (h = 0.800-0.928), while nucleotide diversity estimates were low (pi = 0.0034-0.0053). The distribution of pairwise nucleotide differences fits well with expectations of a "sudden expansion" model. High haplotype diversity was accompanied by relatively high expected heterozygosity (H(E)) values in nuclear genes (calculated over 47 enzyme loci: H(E) = 0.031 - 0.049), giving no evidence for a recent bottleneck after the process of post-Pleistocene recolonization of Poland by the shrews. Thus, for S. araneus chromosome races in Poland, the data on the cytochrome b gene variability support the hypothesis assuming the Robertsonian fusions having spread into an ancestral acrocentric distribution.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920129     DOI: 10.1038/sj.hdy.6800032

Source DB:  PubMed          Journal:  Heredity (Edinb)        ISSN: 0018-067X            Impact factor:   3.821


  1 in total

1.  Phenotypic variation across chromosomal hybrid zones of the common shrew (Sorex araneus) indicates reduced gene flow.

Authors:  P David Polly; Andrei V Polyakov; Vadim B Ilyashenko; Sergei S Onischenko; Thomas A White; Nikolay A Shchipanov; Nina S Bulatova; Svetlana V Pavlova; Pavel M Borodin; Jeremy B Searle
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.